Causes of Premenstrual Syndrome (PMS)
User reported causes of Premenstrual Syndrome (PMS) based on their intuition.
| Cause | Agree |
|---|---|
| Hormone Imbalance | 70% |
| Stress | 64% |
| History of Depression | 49% |
| Family History | 43% |
| Lack of Exercises | 43% |
| Poor Diet | 35% |
| Caffeine | 29% |
| Gluten Intolerance | 18% |
| B6 Deficiency | 16% |
| Adrenal Insufficiency | 15% |
| Tobacco | 5% |
Treatments
User-reported effectiveness in treating Premenstrual Syndrome (PMS)
| Treatment | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
|---|---|---|---|---|---|---|
| Codeine | 0% | 100% | 0% | 0% | 0% | 1 |
| Ibuprofen | 17% | 52% | 4% | 24% | 2% | 92 |
| Exercise | 9% | 45% | 6% | 33% | 8% | 89 |
| Naproxen (Aleve) | 31% | 31% | 8% | 23% | 8% | 13 |
| Tai Chi | 0% | 17% | 0% | 50% | 33% | 6 |
| Low Dose Naltrexone (LDN) | 0% | 25% | 0% | 75% | 0% | 4 |
| Heat | 12% | 65% | 0% | 20% | 2% | 49 |
| Tylenol | 5% | 34% | 0% | 57% | 5% | 44 |
| Magnesium | 13% | 18% | 0% | 63% | 8% | 40 |
| Meditation | 3% | 44% | 0% | 50% | 3% | 34 |
| Fish Oil | 6% | 12% | 2% | 78% | 2% | 50 |
| Vitamin B6 | 10% | 13% | 0% | 75% | 3% | 40 |
| Vitamin E | 0% | 11% | 4% | 78% | 7% | 27 |
| Evening Primrose Oil | 10% | 5% | 10% | 76% | 0% | 21 |
| Adequate Sleep | 10% | 35% | 0% | 51% | 4% | 80 |
| Cannabis | 13% | 53% | 7% | 20% | 7% | 15 |
| Zinc | 6% | 6% | 0% | 82% | 6% | 17 |
| Prayer | 8% | 31% | 15% | 38% | 8% | 13 |
| Balancing Hormones | 35% | 50% | 0% | 15% | 0% | 20 |
| Midol | 13% | 55% | 3% | 28% | 3% | 40 |
| Massage (Breasts, Abdomen) | 7% | 57% | 0% | 29% | 7% | 28 |
| Bio-Identical Progesterone | 100% | 0% | 0% | 0% | 0% | 1 |
| Decreased Caffeine | 19% | 21% | 0% | 55% | 4% | 47 |
| Reduce Sugar Intake | 6% | 47% | 3% | 44% | 0% | 36 |
| DIM | 50% | 0% | 0% | 50% | 0% | 2 |
| Dark Chocolate | 7% | 34% | 0% | 59% | 0% | 41 |
| Sertraline | 0% | 60% | 0% | 40% | 0% | 5 |
| Fluoxetine | 21% | 26% | 11% | 42% | 0% | 19 |
| Clary Sage Essential Oil (Therapeutic Quality) | 0% | 50% | 0% | 50% | 0% | 4 |
| Crill Oil | 0% | 50% | 0% | 50% | 0% | 2 |
| Reduce Sodium Intake | 8% | 40% | 4% | 36% | 12% | 25 |
| Counseling | 8% | 27% | 4% | 58% | 4% | 26 |
| Vitex (Chaste Tree Berry) | 13% | 25% | 13% | 50% | 0% | 8 |
| 5-Hydroxytryptophan (5HTP) | 0% | 22% | 0% | 78% | 0% | 9 |
| Desvenlafaxine | 33% | 0% | 33% | 33% | 0% | 3 |
| Tryptophan | 14% | 0% | 14% | 71% | 0% | 7 |
| Manganese | 0% | 0% | 0% | 100% | 0% | 13 |
| Paroxetine | 0% | 0% | 17% | 83% | 0% | 6 |
| Wellbutrin | 0% | 24% | 12% | 59% | 6% | 17 |
| Calcium Supplements | 5% | 8% | 5% | 76% | 5% | 38 |
| Contraceptive | 10% | 35% | 22% | 25% | 8% | 79 |
| Increased Fiber | 0% | 18% | 8% | 63% | 11% | 38 |
Outcomes
Below is the degree of change seen after Premenstrual Syndrome (PMS) is higher than average.
|
|
Predictors
Below is the change in Premenstrual Syndrome (PMS) seen after the predictor is higher than average.
|
|
Outcomes Label
Predictors Label
Premenstrual Syndrome (PMS) Info
| Property | Value |
|---|---|
| Variable Name | Premenstrual Syndrome (PMS) |
| Aggregation Method | MEAN |
| Analysis Performed At | 2020-03-02 |
| Duration of Action | 24 hours |
| Maximum Allowed Value | 5 out of 5 |
| Minimum Allowed Value | 1 out of 5 |
| Number of Aggregate Predictors | 0 |
| Number of Aggregate Outcomes | 0 |
| Number of Measurements | 0 |
| Number of Measurements (including those generated by tagged, joined, or child variables) | 0 |
| Public | true |
| Onset Delay | 0 seconds |
| Unit | 1 to 5 Rating |
| User Variables | 1 |
| Variable Category | Symptoms |
| Variable ID | 86895 |